ReviewBiomimetics (Basel, Switzerland)2026
Recent Advances in Microelectrode Array Interfaces for Organoids.
Review in Biomimetics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Electrophysiological studies using brain organoids provide valuable insights into neurological disorders and offer promising opportunities for therapeutic development. Accordingly, conventional two-dimensional microelectrode arrays (MEAs) are commonly employed to record neural activity with high spatiotemporal resolution. However, their measurements are mainly limited to the basal surface of the tissue. This limitation restricts the comprehensive analysis of the complex three-dimensional (3D) neural networks formed within organoids. To bridge this gap, this review summarizes recent advances in 3D MEA technologies, with a focus on device geometries, electrode designs, and neural signal acquisition strategies ranging from noninvasive to invasive approaches. Among these advances, photolithography-based fabrication processes have enabled submicron-scale structures, improving device flexibility, spatial resolution, and signal-to-noise ratio. Furthermore, the integration of 3D MEAs with perfusion systems and shape-transformable architectures facilitates stable, long-term electrophysiological monitoring of organoids. Finally, this review discusses emerging research trends and future perspectives in 3D MEA development in organoid-based neuroscience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.